share_log

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Agwunobi John O

bluebird bio | 4: Statement of changes in beneficial ownership of securities-Director Agwunobi John O

bluebird bio | 4:持股变动声明-董事 Agwunobi John O
美股SEC公告 ·  11/08 16:16

Moomoo AI 已提取核心信息

On November 6, 2024, John O Agwunobi, associated with bluebird bio, Inc. [BLUE], completed a stock transaction involving the grant of 24,900 shares of common stock at no cost. Following this transaction, Agwunobi's direct holdings in the company increased to a total of 51,364 shares. The grant, which is a common form of compensation for executives and directors, reflects the company's commitment to aligning the interests of its leadership with those of its shareholders.
On November 6, 2024, John O Agwunobi, associated with bluebird bio, Inc. [BLUE], completed a stock transaction involving the grant of 24,900 shares of common stock at no cost. Following this transaction, Agwunobi's direct holdings in the company increased to a total of 51,364 shares. The grant, which is a common form of compensation for executives and directors, reflects the company's commitment to aligning the interests of its leadership with those of its shareholders.
2024年11月6日,与蓝鸟生物公司有关的John O Agwunobi完成了一项股票交易,涉及无偿授予24,900股普通股。 在这次交易之后,Agwunobi在该公司的直接持股总数增至51,364股。 这项授予是对高管和董事常见的补偿形式,反映了公司致力于使其领导层的利益与股东的利益保持一致。
2024年11月6日,与蓝鸟生物公司有关的John O Agwunobi完成了一项股票交易,涉及无偿授予24,900股普通股。 在这次交易之后,Agwunobi在该公司的直接持股总数增至51,364股。 这项授予是对高管和董事常见的补偿形式,反映了公司致力于使其领导层的利益与股东的利益保持一致。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息